Skip to content
DataLookout
Menu

NCT07592611

Deep Brain Stimulation for Treatment-Resistant Schizophrenia

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date pushed from Nov 1, 2026 to Jan 1, 2027
  2. Notable Start date pushed from Oct 1, 2026 to Nov 1, 2026
    • Eligibility criteria expanded, about 21 words
    • Secondary endpoints: details revised at 2 of 2 entries
  3. Notable Start date: Sep 1, 2026 to Oct 1, 2026v4
  4. Notable Start date: Aug 1, 2026 to Sep 1, 2026v3
  5. Notable Start date: Jun 1, 2026 to Aug 1, 2026v2
  6. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change from baseline in the Brief Psychiatric Rating Scale
Timeframe: 1 year after neurostimulator implantation
Change from baseline in the Scales for the Assessment of Negative Symptoms (SANS)
Timeframe: 1 year after neurostimulator implantation
Incidence of adverse device effects (ADEs).
Timeframe: 1 year after neurostimulator implantation

Secondary (2)

Change from baseline in the Young Mania scale (YMS)
Change from baseline in the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) cognitive test battery.

Arms and interventions

Deep Brain Stimulation ImplantExperimental

Unblinded treatment arm, deep brain stimulation of the substantia nigra pars reticulata for treatment resistant schizophrenia.

Devices: Medtronic Percept with SensSight Deep Brain Stimulation System

Sites

1 site in 1 country

  • The Johns Hopkins HospitalBaltimore, Maryland, United States